Several of the nation?s top experts in pandemic, bioterrorism, and disaster readiness will be on hand next week at the premier annual gathering of preventive medicine and public health leaders to discuss public health preparedness and response efforts at the national, state, and local levels.
According to a new study from the Stanford University School of Medicine, the incidence of heart disease and associated fatalities are higher for people who live in poor neighborhoods verses those who live in more affluent areas.
Johns Hopkins cardiologists are calling for an expansion of the criteria widely used by physicians to detect and assess a postmenopausal woman’s chances of developing cardiovascular disease, the leading cause of death among women in the United States.
The contaminant bisphenol-A (BPA) — widely used to make many plastics found in food storage containers and dental products — can have long-term effects in female development, according to a recent study by Yale School of Medicine researchers.
Led by researchers at Weill Cornell Medical College in New York City, an international group of scientists has pinpointed a specific genetic relationship as the cause of dangerous iron overload in persons with a form of the inherited blood disease, beta-thalassemia.
A featured paper in the February 14 issue of Nature Cancer Gene Therapy demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors, based upon a fundamental new understanding of the differences between cancerous and normal liver cells.
Leading players in the mobile phone industry and the U.S. Government have joined forces to fight HIV/AIDS and other health challenges in 10 African countries.
University of Iowa researchers have learned more about a genetic variation that is a small risk factor for a mild form of schizophrenia yet also is associated with improved overall survival.
Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
People from lower socioeconomic backgrounds who suffer a heart attack come to the emergency department more often, are less likely to be treated aggressively and have higher mortality rates a year after the attack, says new University of Alberta research that has important implications for access to cardiac care.